1 / 18

ANTI-CATHEPSIN B MARKET ANALYSIS

Anti-Cathespin B antibodies are majorly used for treatment of disease conditions such cancer, traumatic brain injury, Ebola infection, fertility problems, and are currently under research for treatment of SARS-CoV-2. Cathepsins play an important role in protein degradation and processing. Aberrant cathepsin B or L is closely associated with many diseases such as cancer, osteoporosis and autoimmune disorders. Therefore, development of potent and selective cathepsin B and L inhibitors has generated much attention in recent years. Although, several classes of cathepsin inhibitors are presently available, there are still some problems to solve such as a broad-spectrum inhibition to protease, especially cysteine proteases, which lead to unpredictable side effects in clinical trials.

yuvhaan
Download Presentation

ANTI-CATHEPSIN B MARKET ANALYSIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ANTI-CATHEPSIN B MARKET ANALYSIS • Anti-Cathespin B antibodies are majorly used for treatment of disease conditions such cancer, traumatic brain injury, Ebola infection, fertility problems, and are currently under research for treatment of SARS-CoV-2. Cathepsins play an important role in protein degradation and processing. Aberrant cathepsin B or L is closely associated with many diseases such as cancer, osteoporosis and autoimmune disorders. Therefore, development of potent and selective cathepsin B and L inhibitors has generated much attention in recent years. Although, several classes of cathepsin inhibitors are presently available, there are still some problems to solve such as a broad-spectrum inhibition to protease, especially cysteine proteases, which lead to unpredictable side effects in clinical trials. • Anti-Cathepsin B antibodies are available from several suppliers. In humans, this protein is encoded by the gene CTSB. The protein may also be known as APPS, CPSB, RECEUP, APP secretase, and amyloid precursor protein secretase. These anti-Cathepsin B antibodies are used for ELISA, western blotting, flow cytometry and other screening purposes.

  2. Market Dynamics • The increasing research and development of anti-cathepsin B antibodies is expected to contribute to the anti-cathespin B market growth over the forecast period. For instance, according to the Springer Nature Journal’s report of July 2017, the effect of cathepsin B inhibitor, E-64, on developmental competency and cryo-survival of pre-implantation ovine IVF derived embryos was assessed. During the test, 1.0 μM of E-64 (Cathepsin B inhibitor) was added during day 3 to 8 of development of blastocyst in IVF derived embryos. And the results showed that the supplementation of IVC media with 1 μM E-64, an exogenous inhibitor of Cathepsins, improves quality and quantity of blastocyst formation. And hence, support the in vitro ovine embryos survival. • Furthermore, there are many developments in research of anti-cathepsin B antibodies. Many researchers are working on finding a cure with the help of anti-cathepsin B antibodies for diseases such as Alzheimer’s disease, rheumatism arthritis, tumor invasion and metastasis, inflammatory airway disease, chronic obstructive pulmonary disease, osteoarthritis, pneumocystis carinii, acute pancreatitis, and bone and joint disorders.

  3. Key features of the study: • This report provides in-depth analysis of the global anti-cathespin B market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players

  4. It profiles key players in the global anti-cathespin B market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies • Key players covered as a part of this study are Merck KGaA, Bio-Techne, BioVision Inc., Santa Cruz Biotechnology, Inc., MedChemExpress, BioCat GmbH, ApexBio Technology, Cayman Chemical, Selleck Chemicals, BOC Sciences, AG Scientific, Virobay Inc. and Abcam Plc. • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics • The global anti-cathespin B market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for anti-cathespin B market, research and consulting firms, new entrants, and financial analysts. • Request free PDF brochure of anti-cathepsin b market analysis • Request free sample copy of anti-cathepsin b market analysis

  5. Detailed Segmentation: • Global Anti-Cathespin B Market, By Type: • Primary Antibodies • Proteins and Peptides • Lysates • Global Anti-Cathespin B Market, By Research Application: • Cancer • Traumatic Brain Injury • Ebola Infection • Fertility Treatment • Others

  6. Global Anti-Cathespin B Market, By Technique: • Immunohistochemistry • Immunofluorescence • Western Blotting • ELISA • Flow Cytometry • Others • Global Anti-Cathespin B Market, By End User: • Pharmaceutical Companies • Academic and Research Institutes • Global Anti-Cathespin B Market, By Region: • North America • By Country: • U.S. • Canada • By Type: • Primary Antibodies • Proteins and Peptides • Lysates

  7. By Research Application: • Cancer • Traumatic Brain Injury • Ebola Infection • Fertility Treatment • Others • By Technique: • Immunohistochemistry • Immunofluorescence • Western Blotting • ELISA • Flow Cytometry • Others • By End User: • Pharmaceutical Companies • Academic and Research Institutes

  8. Europe • By Country: • U.K. • Germany • Italy • Spain • France • Russia • Rest of Europe • By Type: • Primary Antibodies • Screening Kits • Proteins and Peptides • Lysates • By Research Application: • Cancer • Traumatic Brain Injury • Ebola Infection • Fertility Treatment • Others

  9. By Technique: • Immunohistochemistry • Immunofluorescence • Western Blotting • ELISA • Flow Cytometry • Others • By End User: • Pharmaceutical Companies • Academic and Research Institutes • Asia Pacific • By Country: • Australia • India • China • Japan • ASEAN • South Korea • Rest of Asia Pacific

  10. By Type: • Primary Antibodies • Screening Kits • Proteins and Peptides • Lysates • By Research Application: • Cancer • Traumatic Brain Injury • Ebola Infection • Fertility Treatment • Others • By Technique: • Immunohistochemistry • Immunofluorescence • Western Blotting • ELISA • Flow Cytometry • Others • By End User: • Pharmaceutical Companies • Academic and Research Institutes

  11. Latin America • By Country: • Brazil • Mexico • Argentina • Rest of Latin America • By Type: • Primary Antibodies • Screening Kits • Proteins and Peptides • Lysates • By Research Application: • Cancer • Traumatic Brain Injury • Ebola Infection • Fertility Treatment • Others

  12. By Technique: • Immunohistochemistry • Immunofluorescence • Western Blotting • ELISA • Flow Cytometry • Others • By End User: • Pharmaceutical Companies • Academic and Research Institutes • Middle East • By Country: • GCC • Israel • Rest of Middle East • By Type: • Primary Antibodies • Screening Kits • Proteins and Peptides • Lysates

  13. By Research Application: • Cancer • Traumatic Brain Injury • Ebola Infection • Fertility Treatment • Others • By Technique: • Immunohistochemistry • Immunofluorescence • Western Blotting • ELISA • Flow Cytometry • Others • By End User: • Pharmaceutical Companies • Academic and Research Institutes

  14. Africa • By Country/Region: • South Africa • Central Africa • North Africa • By Type: • Primary Antibodies • Screening Kits • Proteins and Peptides • Lysates • By Research Application: • Cancer • Traumatic Brain Injury • Ebola Infection • Fertility Treatment • Others

  15. By Technique: • Immunohistochemistry • Immunofluorescence • Western Blotting • ELISA • Flow Cytometry • Others • By End User: • Pharmaceutical Companies • Academic and Research Institutes

  16. Company Profiles • Merck KGaA* • Company Overview • Product Portfolio • Financial Performance • Recent Highlights • Strategies • Bio-Techne • BioVision Inc. • Santa Cruz Biotechnology, Inc. • MedChemExpress • BioCat GmbH • ApexBio Technology • Cayman Chemical • Selleck Chemicals • BOC Sciences • AG Scientific • Virobay Inc. • Abcam Plc

  17. ABOUT US • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: CMI Services: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  18. CONTACT US Mr. Shah Coherent Market Insights Pvt Ltd, 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com Related links: • CMI Blogs • CMI News • CMI Infographics

More Related